Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

CNBX Pharmaceuticals (CNBX) Return on Capital Employed (2016 - 2025)

CNBX Pharmaceuticals (CNBX) has disclosed Return on Capital Employed for 12 consecutive years, with 0.12% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 6.0% year-over-year to 0.12%, compared with a TTM value of 0.12% through Nov 2025, down 6.0%, and an annual FY2025 reading of 0.11%, down 15.0% over the prior year.
  • Return on Capital Employed was 0.12% for Q4 2025 at CNBX Pharmaceuticals, up from 0.11% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 19.85% in Q1 2022 and bottomed at 2.76% in Q4 2021.
  • Average Return on Capital Employed over 5 years is 1.17%, with a median of 0.26% recorded in 2024.
  • The sharpest move saw Return on Capital Employed soared 2110bps in 2022, then crashed -1897bps in 2023.
  • Year by year, Return on Capital Employed stood at 2.76% in 2021, then soared by 142bps to 1.17% in 2022, then crashed by -68bps to 0.37% in 2023, then tumbled by -52bps to 0.18% in 2024, then plummeted by -35bps to 0.12% in 2025.
  • Business Quant data shows Return on Capital Employed for CNBX at 0.12% in Q4 2025, 0.11% in Q3 2025, and 0.08% in Q2 2025.